Blood lipids of patients with chronic hepatitis: Differences related to viral etiology

被引:71
作者
Fabris, C [1 ]
Federico, E [1 ]
Soardo, G [1 ]
Falleti, E [1 ]
Pirisi, M [1 ]
机构
[1] UNIV UDINE,DIPARTIMENTO PATOL & MED SPERIMENTALE & CLIN,I-33100 UDINE,ITALY
关键词
cholesterol; liver function; viral hepatitis;
D O I
10.1016/S0009-8981(97)06532-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In order to investigate whether a difference might exist in blood cholesterol and its subtractions between patients with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, serum cholesterol, HDL-cholesterol, triglycerides and common liver function tests were measured in 138 patients (92 male, 46 female) with biopsy-proven chronic viral hepatitis without cirrhosis. Twenty-four had hepatitis B and 114 hepatitis C. Mean serum cholesterol was lower in HCV-infected in comparison to HBV-infected patients (175 +/- 36 mg/dl vs. 189 +/- 28 mg/dl, p < 0.05). On multivariate analysis, etiology of hepatitis appeared to be associated with the value of serum cholesterol, independently of age, sex and liver synthetic function (improvement of chi-square 4.40, p < 0.05). In patients with HBV infection, circulating tumor necrosis factor-cw demonstrated a correlation with serum triglycerides (rho = 0.618) and an inverse correlation with serum HDL-cholesterol (rho = - 0.456); in the group of patients with HCV infection, interleukin-6 correlated with triglycerides (rho = 0.370) and HDL-cholesterol (rho = - 0.355). Thus, differences in the mechanisms of liver damage and of viral clearance in hepatitis C in comparison to hepatitis B, reflected in these patients by the levels of circulating cytokines, may be mirrored by differences in their blood lipid composition. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 16 条
  • [1] METABOLIC RESPONSE TO INFECTION
    BEISEL, WR
    [J]. ANNUAL REVIEW OF MEDICINE, 1975, 26 : 9 - 20
  • [2] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
  • [3] Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa
    Cacciarelli, TV
    Martinez, OM
    Gish, RG
    Villanueva, JC
    Krams, SM
    [J]. HEPATOLOGY, 1996, 24 (01) : 6 - 9
  • [4] CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2
  • [5] SERUM LEVELS OF INTERFERON-ALPHA AND INTERFERON-GAMMA IN ACUTE AND CHRONIC HEPATITIS-B VIRUS-INFECTION
    CHU, CM
    SHEEN, IS
    YEH, CT
    HSIEH, SY
    TSAI, SL
    LIAW, YF
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (10) : 2107 - 2112
  • [6] AN ANTIVIRAL SOLUBLE FORM OF THE LDL RECEPTOR-INDUCED BY INTERFERON
    FISCHER, DG
    TAL, N
    NOVICK, D
    BARAK, S
    RUBINSTEIN, M
    [J]. SCIENCE, 1993, 262 (5131) : 250 - 253
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] THE ROLE OF THE CYTOKINES, INTERFERON-ALPHA AND TUMOR-NECROSIS-FACTOR IN THE HYPERTRIGLYCERIDEMIA AND WASTING OF AIDS
    GRUNFELD, C
    FEINGOLD, KR
    [J]. JOURNAL OF NUTRITION, 1992, 122 (03) : 749 - 753
  • [9] GRUNFELD C, 1992, P SOC EXP BIOL MED, V200, P224
  • [10] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GRUNFELD, C
    PANG, MY
    DOERRLER, W
    SHIGENAGA, JK
    JENSEN, P
    FEINGOLD, KR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) : 1045 - 1052